Janney Montgomery Scott’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Sell
31,374
-1,281
-4% -$52.8K ﹤0.01% 1545
2025
Q4
$1.34M Sell
32,655
-6,154
-16% -$243K ﹤0.01% 1565
2025
Q3
$1.45M Buy
38,809
+334
+0.9% +$12.1K ﹤0.01% 1484
2025
Q2
$1.4M Buy
38,475
+3,401
+10% +$123K ﹤0.01% 1385
2025
Q1
$1.35M Buy
35,074
+2,287
+7% +$90.7K ﹤0.01% 1356
2024
Q4
$1.24M Buy
32,787
+9,455
+41% +$378K ﹤0.01% 1418
2024
Q3
$978K Sell
23,332
-3,529
-13% -$146K ﹤0.01% 1520
2024
Q2
$1.1M Sell
26,861
-976
-4% -$38.8K ﹤0.01% 1397
2024
Q1
$1.15M Buy
27,837
+2,122
+8% +$88.9K ﹤0.01% 1439
2023
Q4
$1.04M Buy
25,715
+809
+3% +$30.9K ﹤0.01% 1426
2023
Q3
$975K Buy
24,906
+525
+2% +$20.9K ﹤0.01% 1358
2023
Q2
$991K Sell
24,381
-867
-3% -$35.7K ﹤0.01% 1416
2023
Q1
$1.06M Sell
25,248
-1,490
-6% -$62.7K ﹤0.01% 1282
2022
Q4
$1.17M Sell
26,738
-184
-0.7% -$7.82K ﹤0.01% 1284
2022
Q3
$1.04M Buy
26,922
+1,070
+4% +$45.6K ﹤0.01% 1285
2022
Q2
$1.09M Buy
25,852
+3,108
+14% +$135K ﹤0.01% 1195
2022
Q1
$1.03M Buy
22,744
+1,190
+6% +$52.7K ﹤0.01% 1227
2021
Q4
$1.04M Buy
21,554
+6,587
+44% +$312K ﹤0.01% 1304
2021
Q3
$713K Buy
14,967
+1,232
+9% +$60K ﹤0.01% 1460
2021
Q2
$666K Buy
13,735
+680
+5% +$32.5K ﹤0.01% 1472
2021
Q1
$604K Sell
13,055
-800
-6% -$37.9K ﹤0.01% 1448
2020
Q4
$659K Sell
13,855
-825
-6% -$37.4K ﹤0.01% 1402
2020
Q3
$629K Hold
14,680
﹤0.01% 1320
2020
Q2
$599K Sell
14,680
-300
-2% -$12.1K ﹤0.01% 1277
2020
Q1
$540K Buy
14,980
+110
+0.7% +$4.38K ﹤0.01% 1184
2019
Q4
$632K Buy
14,870
+425
+3% +$16.9K ﹤0.01% 1303
2019
Q3
$553K Buy
14,445
+300
+2% +$11.5K ﹤0.01% 1332
2019
Q2
$550K Sell
14,145
-375
-3% -$14.3K ﹤0.01% 1375
2019
Q1
$578K Buy
14,520
+845
+6% +$33.4K ﹤0.01% 1315
2018
Q4
$498K Buy
13,675
+49
+0.4% +$1.93K ﹤0.01% 1296
2018
Q3
$580K Sell
13,626
-1,079
-7% -$43.7K 0.01% 1374
2018
Q2
$567K Hold
14,705
0.01% 1316
2018
Q1
$515K Buy
14,705
+372
+3% +$13.2K 0.01% 1316
2017
Q4
$523K Buy
14,333
+900
+7% +$32.5K 0.01% 1283
2017
Q3
$490K Sell
13,433
-250
-2% -$9.09K 0.01% 1265
2017
Q2
$501K Sell
13,683
-67
-0.5% -$2.35K 0.01% 1174
2017
Q1
$476K Sell
13,750
-200
-1% -$6.72K 0.01% 1184
2016
Q4
$443K Buy
13,950
+1,100
+9% +$36.9K 0.01% 1135
2016
Q3
$442K Buy
+12,850
New +$454K 0.01% 1017
2016
Q2
Sell
-12,700
Closed -$450K 721
2016
Q1
$450K Hold
12,700
0.01% 818
2015
Q4
$500K Buy
12,700
+200
+2% +$8.15K 0.01% 808
2015
Q3
$470K Buy
12,500
+750
+6% +$33.2K 0.01% 864
2015
Q2
$503K Sell
11,750
-745
-6% -$32K 0.01% 1171
2015
Q1
$537K Buy
12,495
+1,095
+10% +$45.7K 0.01% 1321
2014
Q4
$487K Hold
11,400
0.01% 1332
2014
Q3
$438K Buy
11,400
+1,500
+15% +$55.2K 0.01% 1381
2014
Q2
$364K Buy
9,900
+500
+5% +$18.1K 0.01% 1461
2014
Q1
$348K Sell
9,400
-600
-6% -$22.1K 0.01% 1357
2013
Q4
$354K Buy
10,000
+1,000
+11% +$33.6K 0.01% 1315
2013
Q3
$293K Buy
+9,000
New +$299K 0.01% 1351

Other funds holding BME

Janney Montgomery Scott's BME Position: Q1 2026 in Review

Janney Montgomery Scott reduced its BlackRock Health Sciences Trust (BME) stake by 3.9% in Q1 2026, selling an estimated $52.8K and leaving 31,374 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Janney Montgomery Scott first reported a position in BME in Q3 2013 and has held it in 50 quarters since. The position peaked at $1.45M in Q3 2025. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Janney Montgomery Scott held 31,374 shares of BlackRock Health Sciences Trust worth $1.21M as of Q1 2026.
  • Janney Montgomery Scott sold 1,281 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $52.8K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #1545 holding.
  • Janney Montgomery Scott first reported a position in BlackRock Health Sciences Trust in Q3 2013 and has held it in 50 quarters since.
  • Janney Montgomery Scott's BlackRock Health Sciences Trust position peaked at $1.45M in Q3 2025.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.